Skip to content

Nalu Medical, Inc. 71002-USRecalls & reported problems

Nalu Medical, Inc. · Nalu Neurostimulation Kit (Integrated, Dual 8, 40 cm) · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00812537030494), received between Dec 17, 2020 and Dec 17, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 17, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT WAS IMPLANTED WITH AN IPG ON (B)(6) 2019. HE HAS HAD LEAD MIGRATION SINCE (B)(6) OF 2019, WHICH HAS BEEN MITIGATED BY PROGRAMMING STRATEGIES. HOWEVER, ON (B)(6) 2020, PATIENT DECIDED THAT HE WOULD LIKE TO HAVE A REVISION TO OPTIMIZE HIS THERAPY OPTIONS AND EFFICACY. THE REVISION PROCEDURE WAS PERFORMED (B)(6) 2020.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11029037 ↗

Other Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices

All Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page